AbbVie Completes Acquisition of Capstan Therapeutics
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| AbbVie (NYSE: ABBV) | Delayed: 285.64 +0.45 (0.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $285.19 | 52 Week High | $68.12 | |||
| Open | $284.58 | 52 Week Low | $50.71 | |||
| Day High | $286.77 | P/E | 61.96 | |||
| Day Low | $282.30 | EPS | $4.61 | |||
| Volume | 4,631,852 | |||||
